These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 23882747)

  • 1. Folate grafted Prussian Blue entrapped with gadolinium(III) as a new contrast agent for tumor-targeted magnetic resonant imaging.
    Song XX; Liu ZJ; Tang Q
    J Nanosci Nanotechnol; 2013 Aug; 13(8):5233-9. PubMed ID: 23882747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gadolinium (III) oxide nanoparticles coated with folic acid-functionalized poly(β-cyclodextrin-co-pentetic acid) as a biocompatible targeted nano-contrast agent for cancer diagnostic: in vitro and in vivo studies.
    Mortezazadeh T; Gholibegloo E; Alam NR; Dehghani S; Haghgoo S; Ghanaati H; Khoobi M
    MAGMA; 2019 Aug; 32(4):487-500. PubMed ID: 30730021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted tumor dual mode CT/MR imaging using multifunctional polyethylenimine-entrapped gold nanoparticles loaded with gadolinium.
    Zhou B; Xiong Z; Wang P; Peng C; Shen M; Mignani S; Majoral JP; Shi X
    Drug Deliv; 2018 Nov; 25(1):178-186. PubMed ID: 29301434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanoparticles of gadolinium-incorporated Prussian blue with PEG coating as an effective oral MRI contrast agent for gastrointestinal tract imaging.
    Perera VS; Chen G; Cai Q; Huang SD
    Analyst; 2016 Mar; 141(6):2016-22. PubMed ID: 26890149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Composite iron oxide-Prussian blue nanoparticles for magnetically guided T
    Kale SS; Burga RA; Sweeney EE; Zun Z; Sze RW; Tuesca A; Subramony JA; Fernandes R
    Int J Nanomedicine; 2017; 12():6413-6424. PubMed ID: 28919744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tailored ultra-small Prussian blue-based nanoparticles for MRI imaging and combined photothermal/photoacoustic theranostics.
    Fétiveau L; Paul G; Nicolas-Boluda A; Volatron J; George R; Laurent S; Muller R; Sancey L; Mejanelle P; Gloter A; Gazeau F; Catala L
    Chem Commun (Camb); 2019 Dec; 55(98):14844-14847. PubMed ID: 31768507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biofunctionalized gadolinium-containing prussian blue nanoparticles as multimodal molecular imaging agents.
    Dumont MF; Hoffman HA; Yoon PR; Conklin LS; Saha SR; Paglione J; Sze RW; Fernandes R
    Bioconjug Chem; 2014 Jan; 25(1):129-37. PubMed ID: 24328306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biofunctionalized prussian blue nanoparticles for multimodal molecular imaging applications.
    Vojtech JM; Cano-Mejia J; Dumont MF; Sze RW; Fernandes R
    J Vis Exp; 2015 Apr; (98):e52621. PubMed ID: 25993028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oligoethylenimine-grafted chitosan as enhanced T1 contrast agent for in vivo targeted tumor MRI.
    Tong X; Liu M; Zhang K; Cao Y; Dong J; Jiang B; Lu B; Zheng H; Zhang H; Pei R
    J Magn Reson Imaging; 2016 Jul; 44(1):23-9. PubMed ID: 26713668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein-targeted gadolinium-based magnetic resonance imaging (MRI) contrast agents: design and mechanism of action.
    Caravan P
    Acc Chem Res; 2009 Jul; 42(7):851-62. PubMed ID: 19222207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a Gd(III)-based receptor-induced magnetization enhancement (RIME) contrast agent for β-glucuronidase activity profiling.
    Chen SH; Kuo YT; Singh G; Cheng TL; Su YZ; Wang TP; Chiu YY; Lai JJ; Chang CC; Jaw TS; Tzou SC; Liu GC; Wang YM
    Inorg Chem; 2012 Nov; 51(22):12426-35. PubMed ID: 23116118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Properties evaluation of a new MRI contrast agent based on Gd-loaded nanoparticles.
    Riyahi-Alam N; Behrouzkia Z; Seifalian A; Haghgoo Jahromi S
    Biol Trace Elem Res; 2010 Dec; 137(3):324-34. PubMed ID: 20049554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monodispersed plasmonic Prussian blue nanoparticles for zero-background SERS/MRI-guided phototherapy.
    Zhu W; Gao MY; Zhu Q; Chi B; Zeng LW; Hu JM; Shen AG
    Nanoscale; 2020 Feb; 12(5):3292-3301. PubMed ID: 31971195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesoporous NaYbF4@NaGdF4 core-shell up-conversion nanoparticles for targeted drug delivery and multimodal imaging.
    Zhou L; Zheng X; Gu Z; Yin W; Zhang X; Ruan L; Yang Y; Hu Z; Zhao Y
    Biomaterials; 2014 Aug; 35(26):7666-78. PubMed ID: 24929618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highly biocompatible TiO₂:Gd³⁺ nano-contrast agent with enhanced longitudinal relaxivity for targeted cancer imaging.
    Chandran P; Sasidharan A; Ashokan A; Menon D; Nair S; Koyakutty M
    Nanoscale; 2011 Oct; 3(10):4150-61. PubMed ID: 21853215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fabrication and evaluation of tumor-targeted positive MRI contrast agent based on ultrasmall MnO nanoparticles.
    Huang H; Yue T; Xu K; Golzarian J; Yu J; Huang J
    Colloids Surf B Biointerfaces; 2015 Jul; 131():148-54. PubMed ID: 25982318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paramagnetic ultrasmall gadolinium oxide nanoparticles as advanced T1 MRI contrast agent: account for large longitudinal relaxivity, optimal particle diameter, and in vivo T1 MR images.
    Park JY; Baek MJ; Choi ES; Woo S; Kim JH; Kim TJ; Jung JC; Chae KS; Chang Y; Lee GH
    ACS Nano; 2009 Nov; 3(11):3663-9. PubMed ID: 19835389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluorine and Nitrogen Co-Doped Carbon Dot Complexation with Fe(III) as a T
    Wang J; Hu X; Ding H; Huang X; Xu M; Li Z; Wang D; Yan X; Lu Y; Xu Y; Chen Y; Morais PC; Tian Y; Zhang RQ; Bi H
    ACS Appl Mater Interfaces; 2019 May; 11(20):18203-18212. PubMed ID: 31026133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gadolinium chelate with DO3A conjugated 2-(diphenylphosphoryl)-ethyldiphenylphosphonium cation as potential tumor-selective MRI contrast agent.
    Chandrasekharan P; Yong CX; Poh Z; He T; He Z; Liu S; Robins EG; Chuang KH; Yang CT
    Biomaterials; 2012 Dec; 33(36):9225-31. PubMed ID: 23026708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancing T
    Marangoni VS; Neumann O; Henderson L; Kaffes CC; Zhang H; Zhang R; Bishnoi S; Ayala-Orozco C; Zucolotto V; Bankson JA; Nordlander P; Halas NJ
    Proc Natl Acad Sci U S A; 2017 Jul; 114(27):6960-6965. PubMed ID: 28630340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.